Ascletis gets FDA clearance for oral GLP 1 diabetes study
January 06, 2026 | 11:06
The approval allows a longer phase two trial for its oral weight loss and diabetes treatment candidate.
Innovent wins FDA nod, launches lung-cancer race
August 25, 2025 | 15:52
When the IND green light flashed, labs across three continents synchronized—inside the trial that could dethrone chemo kings.
Mobile Version